Evidence map›Paper›PMID 30559407›Full record

ArticleNature microbiology2019

Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life.

Tommi Vatanen, Damian R Plichta, Juhi Somani, Philipp C Münch, Timothy D Arthur, Andrew Brantley Hall, Sabine Rudolf, Edward J Oakeley, Xiaobo Ke, Rachel A Young and 18 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 134 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 1 synthesis or guideline pooled it, 237 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Comparative Genomics and Adaptive Evolution ofFoods (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 11 institutions in 6 countries.

Tommi VatanenBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0949-1291
Damian R PlichtaBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Juhi SomaniDepartment of Computer Science, Aalto University, Espoo, Finland.
Philipp C MünchDepartment for Computational Biology of Infection Research, Helmholtz Center for Infection Research, Brunswick, Germany.
Timothy D ArthurBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Andrew Brantley HallBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Sabine RudolfAnalytical Sciences and Imaging, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Edward J OakeleyChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Xiaobo KeBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Rachel A YoungChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Henry J HaiserChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Raivo KoldeBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Moran YassourBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Kristiina LuopajärviChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Heli SiljanderChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Suvi M VirtanenDepartment of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Jorma IlonenImmunogenetics Laboratory, University of Turku, Turku, Finland.
Raivo UiboDepartment of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Vallo TillmannDepartment of Pediatrics, University of Tartu and Tartu University Hospital, Tartu, Estonia.
Sergei MokurovMinistry of Health and Social Development, Karelian Republic of the Russian Federation, Petrozavodsk, Russia.
Natalya DorshakovaPetrozavodsk State University, Department of Family Medicine, Petrozavodsk, Russia.
Jeffrey A PorterChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Alice C McHardyDepartment for Computational Biology of Infection Research, Helmholtz Center for Infection Research, Brunswick, Germany.ORCID http://orcid.org/0000-0003-2370-3430
Harri LähdesmäkiDepartment of Computer Science, Aalto University, Espoo, Finland.
Hera VlamakisBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Curtis HuttenhowerBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-1110-0096
Mikael KnipChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0003-0474-0033
Ramnik J XavierBroad Institute of MIT and Harvard, Cambridge, MA, USA. xavier@molbio.mgh.harvard.edu.ORCID http://orcid.org/0000-0002-5630-5167
Broad Institute · USUniversity of Helsinki · FIAalto University · FIHelmholtz Centre for Infection Research · DEMinistry of Health of the Russian Federation · RUNovartis (Switzerland) · CHPetrozavodsk State University · RUTampere University · FITartu University Hospital · EEUniversity of Tartu · EEUniversity of Turku · FI

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Autoimmunity Center of Excellence Clinical Research ProgramUM1AI110498 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOFSY, DAVID · 2014 to 2019
$31.4M
A comprehensive platform for novel therapy development from the microbiomeR24DK110499 · NIDDK · BROAD INSTITUTE, INC. · PI HUTTENHOWER, CURTIS · 2017 to 2021
$7.7M
NIAID NIH HHS UM1 AI110498NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R24 DK110499
6 · The paper itself

Abstract

The human gut microbiome matures towards the adult composition during the first years of life and is implicated in early immune development. Here, we investigate the effects of microbial genomic diversity on gut microbiome development using integrated early childhood data sets collected in the DIABIMMUNE study in Finland, Estonia and Russian Karelia. We show that gut microbial diversity is associated with household location and linear growth of children. Single nucleotide polymorphism- and metagenomic assembly-based strain tracking revealed large and highly dynamic microbial pangenomes, especially in the genus Bacteroides, in which we identified evidence of variability deriving from Bacteroides-targeting bacteriophages. Our analyses revealed functional consequences of strain diversity; only 10% of Finnish infants harboured Bifidobacterium longum subsp. infantis, a subspecies specialized in human milk metabolism, whereas Russian infants commonly maintained a probiotic Bifidobacterium bifidum strain in infancy. Groups of bacteria contributing to diverse, characterized metabolic pathways converged to highly subject-specific configurations over the first two years of life. This longitudinal study extends the current view of early gut microbial community assembly based on strain-level genomic variation.

Indexed as

Adaptation, PhysiologicalGenetic VariationGenome, BacterialAge FactorsBacteriophagesBacteroidesBifidobacterium bifidumBifidobacterium longumChild DevelopmentChild, PreschoolEstoniaFecesFemaleFinlandGastrointestinal MicrobiomeHumans

Identifiers

PMID30559407
PMCPMC6384140
OpenAlexW2904950674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.